Health
Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks – News-Medical.Net
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM.
Reviewed by Emily Henderson, B.Sc.Aug 25 2020
The combination of hydroxychloroquine (HCQ) and azithromycin (AZM) has been linked to significant cardiovascular risks, including mortality, in the largest safety study ever performed on both HCQ and HCQ+AZM. This network study, led by the Observational Health Data Sciences and Informatics community, was recently published in Lancet Rheumatology.
OHDSI has established an international network of researchers and observational health databases with a…
-
Noosa News24 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News23 hours agoAustralia Post reintroduces weekend deliveries for Christmas parcel rush
-
Noosa News17 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
Business21 hours agoWhat I’d buy if I had to invest $20,000 in ASX 200 shares before the weekend